புளோரிடா அடிப்படையிலானது சுதந்திரம் ஆரோக்கியம் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

5 Pot Stocks Making Big Moves on the 50th Anniversary of 4/20

Author Bio I love looking at the story behind investments from an interdisciplinary point of view, with an equal appetite for high-growth disruptors and beaten-down value names. Did you know that today marks the 50th 4/20 holiday, the informal holiday celebrated by cannabis users across the world? While accounts of the origin of the term vary, 4/20 was reportedly coined by a group of Northern California high schoolers in 1971. Flash forward 50 years, and while cannabis isn t officially legal at the federal level, there are only six states left in the U.S. in which cannabis is totally illegal in any form. Most U.S. states have legalized at least medical cannabis, and the November elections may have marked a tipping point in recreational cannabis legalization.

New yorkUnited statesPalm bayNew jerseyPalm beach gardensSan franciscoLos angelesSeth rogenLiberty health sciencesJushi holdingsDemocratic senateNorthern californiaSan francisco areaHouseplant san franciscoBay areaNow entering florida

Upcoming Mergers in the Cannabis Industry to Watch

Upcoming Mergers in the Cannabis Industry to Watch © (Getty Images) Glass jar full of Cannabis Sativa for sale at a market stall. The amount of capital raised during the past two months is a strong signal that the cannabis sector is prepping for more acquisitions in 2021 as more states have legalized the adult use of marijuana. We ve already seen a number of deals conducted in late 2020, says Timothy Seymour, founder of Seymour Asset Management in New York and portfolio manager of the Amplify Seymour Cannabis ETF (ticker: CNBS), whose top three holdings are GW Pharmaceuticals (GWPH) at 10.7%, Aphria (APHA) at 8.6% and Canopy Growth Corp. (CGC) at 8.6%.

United statesNew yorkDistrict of columbiaBritish columbiaSan diegoThe west coastNew jerseyJason spataforaMichael bergerPhil murphyAaron raubTimothy seymourJason wildGrowgeneration corpCanopy growth corpPublic companies that could seek

The Week In Cannabis: Epidiolex, Casa Verde, FDA, Michigan, Colombia, And More

The Week In Cannabis: Epidiolex, Casa Verde, FDA, Michigan, Colombia, And More
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

United statesCapitol hillWestern australiaCasa verdeSan franciscoJuan pablo herrera saavedraSeun adedejiDavid bronnerMichael thompsonDan rodaSnoop doggGretchen whitmerKaran wadheraLes szaboTed chungEl planteo

APOGEE SILVER LTD (AGEEF), Canopy Growth Corp (CGC), GW Pharma (GWPH), LIBERTY HEALTH SCI ORD by Liberty Health Sciences Inc (LHSIF), S&P Dep Receipts (SPY) - The Week In Cannabis: Epidiolex, Casa Verde, FDA, Michigan, Colombia, And More

The The The The The In addition, GW Pharmaceuticals plc (NASDAQ:GWPH) published positive results for its Phase 3 clinical trial of Epidiolex oral solution in seizures related to tuberous sclerosis complex in JAMA Neurology. Epidiolex is the first FDA-authorized CBD medicine for children with severe forms of epilepsy. The medicine was first approved for treatments of seizures connected to Lennox-Gastaut syndrome and Dravet syndrome. Michigan Gov. Gretchen Whitmer commuted the sentence of Last Prisoner Project’s constituent Michael Thompson, who spent 25 years in prison after a 1994 arrest of a nonviolent cannabis sale. “I’m thankful to everybody that was involved and I’m thankful to Gov. Whitmer for granting my freedom. It’s been a hard journey but I’m just thankful that no one gave up on me. I want to use my time to help those who can’t help themselves and work for criminal justice reform,” said Thompson.

United statesCapitol hillWestern australiaCasa verdeSan franciscoJuan pablo herrera saavedraSeun adedejiDavid bronnerMichael thompsonDan rodaSnoop doggGretchen whitmerKaran wadheraLes szaboTed chungEl planteo

Ayr Strategies To Purchase Liberty Health Sciences For $290M, Debuts In New Jersey With Garden State Dispensary Deal

Liberty Health Sciences (CSE:LHS) (OTCQX:LHSIF) in a $290-million stock-for-stock transaction. With the deal, Liberty shareholders will obtain roughly 13.1 million new Ayr shares, or 0.03683 Ayr shares for each Liberty share. In addition, Ayr said it will acquire Liberty s Gainesville-based cultivation campus, which spans 387 acres, over 300,000 square feet of production facilities, 28 operating dispensaries and seven ready-to-open dispensaries, as well as seven more in the build-out phase. Ayr s New Jersey Acquisition : The Toronto-based company confirmed it s purchasing the membership interests in the New Jersey-based operator Garden State Dispensary NJ LLC for an upfront payment of $101 million. Pursuant to the deal, Ayr will obtain three open dispensaries, as well as cultivation and production facilities spanning 30,000 square feet, with an additional 75,000 square feet under construction.

Jonathan sandelmanLiberty health sciencesGarden state dispensaryParma wellness centerAyr strategiesFlorida based liberty health sciencesNew jersey acquisitionNew jersey basedசுதந்திரம் ஆரோக்கியம் அறிவியல்தோட்டம் நிலை மருந்தகம்பார்மா ஆரோக்கியம் மையம்அயர் உத்திகள்புளோரிடா அடிப்படையிலானது சுதந்திரம் ஆரோக்கியம் அறிவியல்புதியது ஜெர்சி கையகப்படுத்தல்புதியது ஜெர்சி அடிப்படையிலானது